期刊文献+

IL-22——炎症性疾病关键因子 被引量:26

IL-22: the key cytokine in inflammatory diseases
原文传递
导出
摘要 白细胞介素-22(IL-22)是IL-10细胞因子家族的成员,它参与抗微生物防御,保护和修复组织损伤以及急性期反应。它的信号机制涉及到IL-22与白介素-22受体1(IL-22R1)的结合,以及这个二元复合物和白介素-10受体2(IL-10R2)的胞外域的结合。IL-22不仅可以由辅助T淋巴细胞17(Th17细胞)分泌,而且也可以由Th22,自然杀伤细胞22(NK22)等细胞产生。IL-22的高表达出现在银屑病、异位性皮炎以及溃疡性结肠炎等患者中;而在急性呼吸窘迫综合症和系统性红斑狼疮患者的血清中,IL-22的表达水平下降;这说明了IL-22的表达量与这些疾病的发病情况有着紧密的联系。目前的研究表明IL-22靶向于消化道、皮肤与呼吸器官的非造血细胞,在黏膜固有免疫中起重要作用。本文主要对IL-22的结构、功能、信号通路以及在各种炎症性疾病和自身免疫病中起的作用展开介绍。 Interleukin-22(IL-22) is a member of cytokine IL-10 family,which involved in host's antimicrobial defense,protection and repair of tissue damage and acute phase response.The signaling mechanism includes IL-22 binding to IL-22R1,and this binary complex combines with extracellular domain of IL-10R2.To date,it has been reported that IL-22 can be secreted not only by Th17,but also by Th22,NK22 cells and so on.The high expression of IL-22 appears in patients with psoriasis,atopic dermatitis(AD) and ulcerative colitis.However,IL-22 expression is decreased in serum of patients with acute respiratory distress syndrome and SLE.These data indicate that the expression of IL-22 is associated closly with the severity of these diseases.Current research shows that IL-22 targets non-hematopoietic cells in gastrointestinal tract,skin and respiratory organs rather than T cells,and plays important roles in the mucosal inherent immunity.This paper focuses on the structure,function,and signaling pathways of IL-22,and also its key roles in various inflammatory and autoimmune diseases.
作者 孙奇
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第9期821-825,共5页 Immunological Journal
关键词 TH22细胞 TH17细胞 IL-22 NK-22 银屑病 Th22 cell Th17 cell IL-22 NK-22 Psoriasis
  • 相关文献

参考文献29

  • 1严静,刘涛峰,张虹亚.与银屑病免疫相关的细胞因子研究进展[J].免疫学杂志,2010,26(12):1096-1098. 被引量:8
  • 2M. Caproni,E. Antiga,L. Melani,W. Volpi,E. Del Bianco,P. Fabbri.Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial[J]. Journal of Clinical Immunology . 2009 (2)
  • 3Arasteh J,,Pourpak Z,Ebtekar M,et al.Evaluation of the Ef-fect of IL-22 on Human Cord Blood CD4+T Cellsp. Iran JAllergy Asthma Immunol . 2010
  • 4Ramirez JM,Brembilla NC,Sorg O,et al.Activation of thearyl hydrocarbon receptor reveals distinct requirements forIL-22 and IL-17 production by human T helper cells. European Journal of Immunology . 2010
  • 5Nograles KE,Zaba LC,Guttman-Yassky E,et al.Th17 cy-tokines interleukin(IL)-17 and IL-22 modulate distinct in-flammatory and keratinocyte-response pathways. Br JDermatol . 2008
  • 6Kabashima R,Sugita K,Sawada Y,et al.Increased circulat-ing Th17 frequencies and serum IL-22 levels in patientswith acute generalized exanthematous pustulosis. Journal of the European Academy of Dermatology and Venereology . 2010
  • 7Sonnenberg GF,Nair MG,Kirn TJ,et al.Pathological versusprotective functions of IL-22 in airway inflammation areregulated by IL-17A. The Journal of Experimental Medicine . 2010
  • 8Eyerich S,Eyerich K,Cavani A,et al.IL-17 and IL-22:siblings,not twins. Trends in Immunology . 2010
  • 9Coimbra S,Oliveira H,Reis F,et al.IL-22,IL-17,IL-23,VEGF,TNF-alpha and IL-8 levels in psoriatic patients-before,during and after PUVA and NBUVB therapy. Br JDermatol . 2010
  • 10Guilloteau K,Paris I,Pedretti N,et al.Skin InflammationInduced by the Synergistic Action of IL-17A,IL-22,Onco-statin M,IL-1{alpha},and TNF-{alpha}Recapitulates SomeFeatures of Psoriasis. J Immunol . 2010

二级参考文献17

  • 1Xia YP, Li B, Hylton D, et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis[J].Blood, 2003, 102(1): 161-168.
  • 2Man XY, Yang XH, Cai SQ. Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis regulated by calcium independent of VEGF[J]. J Cell Mol Med, 2008, 2(12):649-660.
  • 3Schonthaler HB, Huggenberger R, Wculek SK,et al. Systemic anti-VEGF treatment strongly reduces skin inflamma- tion in a mouse model of psoriasis [J]. Proc Natl Acad Sci USA, 2009, 106(50): 21264-21269.
  • 4Ravchaudhuri SP, Raychaudhuri SK. Role of NGF and neurogenie inflammation in the pathogenesis of psoriasis[J]. Prog Brain Res, 2004, 146:433-437.
  • 5Presta M, Andres G, Leali D, et al. Inflammatory cells and chemokines sustain FGF2-induced angiogenesis[J]. Eur Cytokine Netw, 2009, 20(2): 39-50.
  • 6Kovacs M, Falchi G, Cardinali S, et al. Immunohistochemical analysis of keratinocyte growth factor and fibrblast growth factor 10 expression in psoriasis [J]. Exp Dermato, 2005, 14(2):130-137.
  • 7Ryu S, Lee JH, Kim SI. IL-17 increased the production of vascularendothelial factor in rheumatoid arthritissynoviocytes [J]. Clin Rheumatol, 2006, 25(1):16-20.
  • 8Anderson E J, McGrath MA, Thalhamer T, et al. Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting [J]. Springer Semin Immunopathol, 2006, 27(4):425-442.
  • 9Simonetti O, Lucarini G, Goteri G. VEGF is likely a keyfactor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemicalstudy [J]. Int J Immunopathol Pharmacol, 2006, 19(4):751-760.
  • 10Rosenberger C, Solovan C, Rosenberger AD, et al. Upregulation of Hypoxia-Inducible Factors in Normal andpsoriatic Skin[J]. J Investig Dermatol, 2007, 127(10): 2445-2452.

共引文献7

同被引文献276

引证文献26

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部